Literature DB >> 21037811

Screening options and recommendations for colorectal cancer.

Timothy M Geiger1, Rocco Ricciardi.   

Abstract

Screening reduces the burden of disease from colorectal cancer through early detection of cancerous lesions and removal of precancerous polyps. The ideal colorectal cancer screening modality should be cost-effective, increase life-years gained, permit long intervals between tests with high patient compliance and low risk to the patient. Although no single colorectal cancer screening method is perfect, several options exist. Government agencies and medical societies have published screening recommendations with differing guidelines; yet, despite the lack of a consistent standard, it is clear that colorectal cancer screening is cost-effective. In this review, the authors address several options for screening, identify risks and benefits, and present methods to risk stratify patients. A thorough discussion with the patient about potential benefits and harms is critical before initiating any screening regimen.

Entities:  

Keywords:  Screening; colonoscopy; colorectal cancer; fecal occult blood test; virtual colonoscopy

Year:  2009        PMID: 21037811      PMCID: PMC2796104          DOI: 10.1055/s-0029-1242460

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  53 in total

1.  A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group.

Authors:  S J Winawer; E T Stewart; A G Zauber; J H Bond; H Ansel; J D Waye; D Hall; J A Hamlin; M Schapiro; M J O'Brien; S S Sternberg; L S Gottlieb
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

2.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.

Authors:  Perry J Pickhardt; J Richard Choi; Inku Hwang; James A Butler; Michael L Puckett; Hans A Hildebrandt; Roy K Wong; Pamela A Nugent; Pauline A Mysliwiec; William R Schindler
Journal:  N Engl J Med       Date:  2003-12-01       Impact factor: 91.245

4.  Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.

Authors:  T F Imperiale; D R Wagner; C Y Lin; G N Larkin; J D Rogge; D F Ransohoff
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

5.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

Authors:  D A Ahlquist; J E Skoletsky; K A Boynton; J J Harrington; D W Mahoney; W E Pierceall; S N Thibodeau; A P Shuber
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

6.  Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I.

Authors:  E Thiis-Evensen; G S Hoff; J Sauar; F Langmark; B M Majak; M H Vatn
Journal:  Scand J Gastroenterol       Date:  1999-04       Impact factor: 2.423

7.  Complications of screening flexible sigmoidoscopy.

Authors:  Theodore R Levin; Carol Conell; Jean A Shapiro; Shella G Chazan; Marion R Nadel; Joe V Selby
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

8.  The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Authors:  M H Robinson; J D Hardcastle; S M Moss; S S Amar; J O Chamberlain; N C Armitage; J H Scholefield; C M Mangham
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

9.  Screening sigmoidoscopy and colorectal cancer mortality.

Authors:  P A Newcomb; R G Norfleet; B E Storer; T S Surawicz; P M Marcus
Journal:  J Natl Cancer Inst       Date:  1992-10-21       Impact factor: 13.506

10.  Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.

Authors:  Nereo Segnan; Carlo Senore; Bruno Andreoni; Hugo Aste; Luigina Bonelli; Cristiano Crosta; Roberto Ferraris; Stefano Gasperoni; Angelo Penna; Mauro Risio; Francesco Paolo Rossini; Stefania Sciallero; Marco Zappa; Wendy S Atkin
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

View more
  19 in total

Review 1.  Computed tomography colonography for the practicing radiologist: A review of current recommendations on methodology and clinical indications.

Authors:  Paola Scalise; Annalisa Mantarro; Francesca Pancrazi; Emanuele Neri
Journal:  World J Radiol       Date:  2016-05-28

Review 2.  Colorectal cancer in the young, many questions, few answers.

Authors:  Kemal I Deen; Hiroshi Silva; Raeed Deen; Pramodh C Chandrasinghe
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

Review 3.  MicroRNA-21 as a potential colon and rectal cancer biomarker.

Authors:  Tao Li; Mei Ha Leong; Bruce Harms; Gregory Kennedy; Lin Chen
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

4.  KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.

Authors:  Yi-Xin Hao; Yong-Mei Li; Ming Ye; Yan-Yan Guo; Qiu-Wen Li; Xiu-Mei Peng; Qi Wang; Shu-Fang Zhang; Hui-Xia Zhao; He Zhang; Guang-Hui Li; Jian-Hua Zhu; Wen-Hua Xiao
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

5.  Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients.

Authors:  Tia Goss Sawhney; Bruce S Pyenson; David Rotter; Michele Berrios; Judy Yee
Journal:  Am Health Drug Benefits       Date:  2018-10

6.  Identification of serum microRNA profiles in colon cancer.

Authors:  E Hofsli; W Sjursen; W S Prestvik; J Johansen; M Rye; G Tranø; H H Wasmuth; I Hatlevoll; L Thommesen
Journal:  Br J Cancer       Date:  2013-04-04       Impact factor: 7.640

7.  Results of faecal immunochemical test for colorectal cancer screening, in average risk population, in a cohort of 1389 subjects.

Authors:  Bogdan Miuţescu; Ioan Sporea; Alina Popescu; Simona Bota; Dana Iovănescu; Amelia Burlea; Liana Mos; Eftimie Miuţescu
Journal:  Clujul Med       Date:  2013-05-09

8.  Public stated preferences and predicted uptake for genome-based colorectal cancer screening.

Authors:  Catharina G M Groothuis-Oudshoorn; Jilles M Fermont; Janine A van Til; Maarten J Ijzerman
Journal:  BMC Med Inform Decis Mak       Date:  2014-03-19       Impact factor: 2.796

9.  Impact of glycemic control on colonoscopy outcomes: bowel preparation and polyp detection.

Authors:  Manhal Izzy; Kinesh Changela; Dhuha Alhankawi; Nami Safai Haeri; Sulay Shah; Ghalib Jibara; Sury Anand; Shashideep Singhal
Journal:  Ann Gastroenterol       Date:  2016-03-03

10.  Assessment of Bone Morphogenetic Protein 3 Methylation in Iranian Patients with Colorectal Cancer.

Authors:  Massoud Houshmand; Mohammad Reza Abbaszadegan; Mohammad Amin Kerachian
Journal:  Middle East J Dig Dis       Date:  2017-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.